Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1250 of 2228 entries
View as:

Bioavailability of BI 1356 BS and Metformin After Co-administration Compared to the Bioavailability of BI 1356 BS Alone and Metformin Alone in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02183506 Org: User:
Start: 09/30/05 End: - Due: -

Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01215097 Org: User:
Start: 10/31/10 End: 04/30/12 Due: 04/30/13

Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT01649271 Org: User:
Start: 07/23/12 End: 06/23/16 Due: 06/23/17

Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02140645 Org: User:
Start: 05/31/14 End: 03/31/15 Due: 03/31/16

Relative Bioavailability of Single Doses of Dabigatran Etexilate in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02173717 Org: User:
Start: 06/30/09 End: - Due: -

Assessment of Chronic Obstructive Pulmonary Disease (COPD) Therapy From the Physicians Perspective Using Tiotropium as an Example

Phase: N/A Priority: Normal
NCT ID: NCT01036763 Org: User:
Start: 01/31/10 End: - Due: -

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02212925 Org: User:
Start: 11/30/06 End: - Due: -

Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease

Phase: N/A Priority: Normal
NCT ID: NCT02238132 Org: User:
Start: 12/31/98 End: - Due: -

Bioequivalence of Empagliflozin and Metformin Given as a Fixed Dose Combination Compared to Single Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01844531 Org: User:
Start: 04/30/13 End: 11/30/13 Due: 11/30/14

Safety, Tolerability and Pharmacokinetics of KUC 7483 Tablets in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02259907 Org: User:
Start: 05/31/03 End: - Due: -

Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo

Phase: N/A Priority: Normal
NCT ID: NCT02240693 Org: User:
Start: 01/15/15 End: 10/09/17 Due: 10/09/18

Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry II

Phase: N/A Priority: Normal
NCT ID: NCT01040793 Org: User:
Start: 01/31/10 End: - Due: -

Temporal Trends of Thrombolysis Treatment in Chinese Acute Ischemic Stroke (AIS) Patients From 2007-2017: Analysis of China National Stroke Registry (CNSR) I, II, and III; CTP-Draft Review Performed;

Phase: N/A Priority: Normal
NCT ID: NCT04290494 Org: User:
Start: 09/21/20 End: 09/30/20 Due: 09/30/21

A Study on Whether Patients Prefer the Spiriva® Respimat® or the Spiriva® Handihaler® for Treating Their Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT03964207 Org: User:
Start: 11/25/19 End: 11/16/21 Due: 11/16/22

Characteristics of Pts Initiating Spiriva Respimat in Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03692676 Org: User:
Start: 03/05/19 End: 10/11/19 Due: 10/11/20

A Study to Test How Healthy Men Tolerate Different Doses of BI 1595043

Phase: N/A Priority: Normal
NCT ID: NCT04789304 Org: User:
Start: 04/01/21 End: 01/14/22 Due: 01/14/23

First Presentation of Parkinson Disease Patients to Neurologist

Phase: N/A Priority: Normal
NCT ID: NCT00802178 Org: User:
Start: 02/28/06 End: - Due: -

A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations

Phase: N/A Priority: Normal
NCT ID: NCT01647711 Org: User:
Start: 07/31/12 End: 09/30/15 Due: 09/30/16

Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)

Phase: N/A Priority: Normal
NCT ID: NCT02240667 Org: User:
Start: 09/18/14 End: 12/31/17 Due: 12/31/18

BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.

Phase: N/A Priority: Normal
NCT ID: NCT02788513 Org: User:
Start: 08/11/16 End: 10/11/19 Due: 10/11/20

A Study in Healthy Japanese Men to Test How Different Doses of BI 1569912 Are Taken up by the Body and How Well They Are Tolerated

Phase: N/A Priority: Normal
NCT ID: NCT04958252 Org: User:
Start: 08/05/21 End: 10/24/23 Due: 10/24/24

Safety and Tolerability of 4 Different Dosage Strengths of BIBW 2992 Tablets to Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02171767 Org: User:
Start: 08/31/09 End: - Due: -

Relative Bioavailability of BI 1015550 Following Oral Administration Under Fed and Fasted Conditions in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03302078 Org: User:
Start: 10/16/17 End: 12/13/17 Due: 12/13/18

Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00152984 Org: User:
Start: 12/31/04 End: 04/30/06 Due: 04/30/07

A Study to Test How Different Doses of BI 456906 Are Tolerated in Japanese Men With a Body Mass Index (BMI) Between 23 and 40 kg/m2

Phase: N/A Priority: Normal
NCT ID: NCT04384081 Org: User:
Start: 06/01/20 End: 01/20/21 Due: 01/20/22